New
York 17 April 2019:
The report “Next
Generation Sequencing (NGS) Market [By Application (Drug
Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious
Diseases, Agricultural & Animal Research, and Others); By Technology (Whole
Genome Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, RNA
Sequencing, Chip Sequencing, De Novo Sequencing, & Methyl Sequencing); By
Products (Instruments, Reagents & Consumables, and Services); By End User
(Healthcare Institutions, Academics, Biotech & Pharma Firms, and Others);
& By Regions]: Market Size & Forecast, 2017 – 2025” According
to a new study published by Polaris Market Research, the global Next Generation
Sequencing (NGS) market is anticipated to reach USD 16.6 billion by 2025.
Request for sample of
this research report @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample
Next generation sequencing (NGS),
is a DNA sequencing technology. The process of DNA sequencing, which decides
the exact order of nucleotides inside a DNA molecule, is known as Next
generation sequencing. Next generation sequencing is high throughput
sequencing. Using next generation
sequencer, the process produces a million DNA molecules and RNA sequences by
allowing rapid nucleotide sequencing. Roche 454 sequencing and Illumina
sequencing are the modern technologies of next generation sequencing.
In comparison to Sanger’s
sequencing method, the next generation sequencing is much cost-effective
technique that provides better outcomes for DNA sequencing. An entire human
genome can be sequenced in a single day using next generation sequencing,
however, the Sanger sequencing technology, used to decode the human genome,
required over a decade to bring the final summary.
By providing high flexibility,
speed, throughput, and reduced sequencing cost, the introduction of next
generation sequencing technologies has brought significant changes in
sequencing technologies. In the single sequencing run, the next generation
sequencing has ability to generate of nucleotide sequence data. The
applications of next generation sequencing are in the field of cancer research,
genetic disease research, personalized medicines, biological drug discovery,
newborn sequencing metgenomics, and agriculture research etc. Moreover,
non-coding RNA expression profiling, identification of binding sites on
transcriptional factor, and re- sequencing of targets are some more
applications of next generation sequencing.
Browse summary of
this report with TOC @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market
The adoption of next generation sequencing
is mounting for diagnosis of inherited genetic disorders, cancer, HLA typing
and identification of infectious diseases as it allows scanning of targeted
genome in very small time, and this is expected to propel the growth of global
next generation sequencing market over the forecast period.
The global market for next
generation sequencing is segmented by application, technology, products, end
user, and region. By application, the global next generation sequencing market
is categorized as, drug discovery/personalized medicine, genetic screening,
diagnostics/infectious diseases, agricultural & animal research, and
others. The drug discovery/personalized medicine segment is estimated to
account major share in global next generation sequencing market by application
in 2017. The increasing demand of next generation sequencing base test for
infectious diseases and cancer, and rising focus on developing and providing
next generation sequencing- based diagnostic tests are the major factors
contributing towards the high market share of the segment in the global market.
Moreover, the growing research and development activities globally are
significantly contributing towards the growth of market.
By Technology, the global next
generation sequencing market is further sub segmented into Whole Genome
Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, RNA Sequencing,
Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. By technology, the
targeted sequencing & Re-sequencing segment accounted major share in global
next generation sequencing market. The targeted sequencing reduces the
sequencing cost, and it is target specified and also requires smaller dataset.
Moreover, increasing demand target specific genomic studies s expected to
propel the growth of segment in the global next generation sequencing market.
Make an Inquiry for
purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/inquire-before-buying
By product, the global next
generation sequencing market is further categorized into instruments, reagents
& consumables, and services. By
consumables, the global next generation sequencing market is further segmented
into sample preparation consumables, and other consumables. The sample
preparation sample includes quality control consumables, library preparation,
DNA fragmentation, end repair, A-tailing, and size selection etc. On the basis
of services, the global next generation market is segmented into data
management services, and sequencing services. The sequencing services segment
includes, Targeted Re-Sequencing, RNA Sequencing Chip-Seq, Methyl-Seq, De Novo
Sequencing etc. where, the data management services includes, NGS storage, management,
NGS data analysis software & workbenches, and NGS data analysis services.
On the basis of end user, the
global next generation sequencing market is further segmented into healthcare
institutions, pharmaceutical & biotechnology companies, research and
academic centers, and others. By end
user, the research and academics segment accounted major share in global next
generation sequencing market. High application of next generation sequencing
tools in research is the one of the key factors contributing towards the high
market share of the segment. The hospitals and clinics segment is expected to
register high CAGR over the forecast period owing to increasing collaboration
between hospitals and biotech and pharmaceutical companies to develop advanced
test kits for diagnosis of diseases.
Some of the key players operating
in global next generation sequencing market are Thermo Fisher Scientific Inc.,
Illumina, Inc., Roche Holding AG, QIAGEN
N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd.,
Pacific Biosciences of California, Inc., GATC Biotech AG, Perkin Elmer, Inc., Agilent Technologies,
Inc., Macrogen, Inc. , and Eurofins Scientific among others.
Check for discount @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-discount-pricing
About
Polaris Market Research
Polaris Market Research is a global
market research and consulting company. The company specializes in providing
exceptional market intelligence and in-depth business research services for our
clientele spread across different enterprises. We at Polaris are obliged to
serve our diverse customer base present across the industries of healthcare,
technology, semi-conductors and chemicals among various other industries
present around the world. We strive to provide our customers with updated
information on innovative technologies, high growth markets, emerging business
environments and latest business-centric applications, thereby helping them
always to make informed decisions and leverage new opportunities. Adept with a
highly competent, experienced and extremely qualified team of experts
comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver
value-added business solutions to our customers.
Contact
us
Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
No comments:
Post a Comment